Institute for Clinical & Economic Review Issues Report Entitled 'Aducanumab for Alzheimer's Disease - Effectiveness and Value'

Press/Media: Expert Comment

PeriodMay 25 2021

Media coverage

1

Media coverage

  • TitleInstitute for Clinical & Economic Review Issues Report Entitled 'Aducanumab for Alzheimer's Disease - Effectiveness and Value'
    Media name/outletTargeted News Service
    CountryUnited States
    Date5/25/21
    PersonsDenver Whittington